Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood - United States
doi 10.1182/blood.v120.21.43.43
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2012
Authors
Publisher
American Society of Hematology